118 results on '"Javaud N"'
Search Results
2. Angiœdèmes par déficit acquis en C1-inhibiteur : recommandations du CREAK pour le diagnostic et la prise en charge
- Author
-
Gobert, D., Bouillet, L., Armengol, G., Coppo, P., Defendi, F., Du-Thanh, A., Hardy, G., Javaud, N., Jeandel, P.-Y., Launay, D., Panayotopoulos, V., Pelletier, F., Boccon-Gibod, I., and Fain, O.
- Published
- 2020
- Full Text
- View/download PDF
3. Edemi generalizzati ed edemi localizzati
- Author
-
Javaud, N. and Fain, O.
- Published
- 2016
- Full Text
- View/download PDF
4. Correction to: Imported falciparum malaria in adults: host- and parasite-related factors associated with severity. The French prospective multicenter PALUREA cohort study
- Author
-
Bruneel, Fabrice, Tubach, Florence, Mira, Jean-Paul, Houze, Sandrine, Gibot, Sebastien, Huisse, Marie-Genevieve, Megarbane, Bruno, Choquet, Christophe, Corne, Philippe, Peytel, Eric, Villers, Daniel, Camus, Christophe, Bouchaud, Olivier, Caumes, Eric, Girard, Pierre-Marie, Simon, Fabrice, Kalloumeh, Antoine, Roy, Carine, Durand, Remy, Le Bras, Jacques, Matheron, Sophie, Wolff, Michel, Mourvillier, B., Aubron, C., Bouadma, L., Regnier, B., d’Ortenzio, E., Matra, R., Bouvet, E., Tourret, J., Dorchies, J., Males, S., Rioux, C., Flicoteaux, R., Yeni, P., Spingler, F., Kargougou, E., Casalino, E., Ollivier, V., Grandchamp, B., Miri, Y., Fresnoy, E., Grelon, F., Asfar, P., Kouatchet, A., Mercat, A., Joly-Guillou, M. L., Kempf, M., Eveillard, M., Daoudal, P., Royer, A., Runge, I., Mathonnet, A., Boulain, T., Bret, L., Hocqueloux, L., Segalin, J. M., Mille, C., Niang, M., Prazuck, T., Fortin, M., Schortgen, F., Brun Buisson, C., Botterel, F., Bretagne, S., Leroy, O., Georges, H., Meybeck, A., Guery, B., Patoz, P., Dhennain, C., Chakarian, D., Azougagh, K., Bonmarchand, G., Abboud, P., Favennec, L., Lemeland, J. F., Petrognani, R., Nau, A., Puidupin, A., Carpentier, J. P., Garnotel, E., Moalic, J. L., Tual, L., Amathieu, R., Dhonneur, G., N’Diaye, M., Jeantils, V., Chassaignon, C., Guillerm, A. L., Riche, D., Javaud, N., Pevirieri, F., Benkel, J., Luis, D., Bon, M. C., Lenoir, G., Bernot, B., Collignon, A., Bemba, D., Poilane, I., Trouillet, J. L., Luyt, C. E., Mirabel, M., Chastre, J., Hochedez, P., Perignon, A., Thellier, M., Danis, M., Faussart, A., Nafziger, J., Gastinne, H., Pichon, N., Ajzenberg, D., Darde, M. L., Jacobs, F., Brivet, F., Veyradier, A., Marfaing-Koka, A., Timsit, J. F., Hammer, L., Maubon, D., Pelloux, H., Pene, F., Charpentier, J., Marque, S., Rousseau, C., Guezennec, P., Troche, G., Bedos, J. P., Eloy, O., Palette, C., Therby, A., Monnier, S., Greder-Bellan, A., Cougot, P., Kuteifan, K., Mootien, Y., Guiot, P., Delarbre, J. M., Kiefer, M. H., Page, B., Vieillard Baron, A., Dunand, J., Loubieres, Y., Ricome, J. L., Peltier, J. Y., Giudicelli, Y., Pelletier, C., Rousseau, J. M., Imbert, P., Rapp, C., Mechai, F., Barruet, R., Debord, T., Pilo, J. E., Cavallo, J. D., Angles, O., Genestal, M., Bretonnière, C., Nicolet, L., Jalin, L., Talarmin, J. P., Grossi, O., Raffi, F., Gay-Andrieu, F., Bompoil, T., Gros, A., Le Tulzo, Y., Revest, M., Fily, F., Chapplain, J. M., Tattevin, P., Michelet, C., Chevrier, S., Guigen, C., Baud, F., Launay, J. M., Gourmel, C., Derouin, F., de Miranda, S., Thiery, G., Legriel, S., Azoulay, E., Schlemmer, B., Colin de Verdieres, N., Lagrange-Xelot, M., Gallien, S., De Castro, N., Pavie, J., Lafaurie, M., Molina, J. M., Sarfati, C., Derouin, F., Jonquet, P., Schved, J. F., Biron, C., Bret, C., Klouche, K., Beraud, P., Cristol, J. P., Gruson, D., Herpe, B., Delacre, M., Castaing, Y., Fialon, P., Vincendeau, P., Vincent, F., Karoubi, P., Cohen, Y., Cordel, H., Prendki, V., Cailhol, J., Abgrall, S., Gros, H., Fantinato, C., Cymbalista, F., Senghor, Y., Memain, N., Thuong, M., Adrie, C., Darques, L., Moret, G., Fraisse, F., Godineau, N., Chaplain, C., Prevel, M., Mary, R. J., Plantefeve, G., Bleichner, G., Mentec, H., Leturdu, F., Hyvernat, H., Bernardin, G., Delaunay, P., Marty, P., Baudel, J. L., Maury, E., Offenstadt, G., Meynard, J. L., Pacanowski, J., Ouazene, Z., Bollens, D., Meyohas, M. C., Fonquerine, L., Belkadi, G., Magne, D., Roux, P., Rusel, L., Ricard, J. D., Dreyfuss, D., Mortier, E., Vinceneux, P., Bloch, M., Galeazzi, G., Charbonneau, P., Duhamel, C., Leclercq, R., Delassus, J. L., Malbec, D., Lusina, D., Broutier, H., Charlier, C., Lanternier, F., Coignard, H., Lortholary, O., Bougnoux, M. E., Consigny, P. H., Simons de Fanti, A., Leguern, A. S., Massin, F., and The PALUREA Study Group
- Published
- 2017
- Full Text
- View/download PDF
5. Angiœdème bradykinique et médecine d’urgence : vers une optimisation des stratégies de prise en charge
- Author
-
Javaud, N., Adnet, F., and Fain, O.
- Published
- 2016
- Full Text
- View/download PDF
6. Prise en charge des angiœdèmes induits par les inhibiteurs de l’enzyme de conversion de l’angiotensine : recommandations du Centre de référence national des angiœdèmes
- Author
-
Nosbaum, A., Bouillet, L., Floccard, B., Javaud, N., Launay, D., Boccon-Gibod, I., and Fain, O.
- Published
- 2013
- Full Text
- View/download PDF
7. Angioedèmes et médecine d’urgence
- Author
-
Javaud, N., primary, Adnet, F., additional, and Fain, O., additional
- Published
- 2022
- Full Text
- View/download PDF
8. Angioedèmes bradykiniques
- Author
-
Javaud, N., Fain, O., and Martin, L.
- Published
- 2013
- Full Text
- View/download PDF
9. Angioedèmes de la luette : une série de 54 patients
- Author
-
Cauchois, E., Ghrenassia, E., Soria, A., Bouillet, L., Boccon-Gibod, I., Marmion, N., Javaud, N., Delphine, G., and Fain, O.
- Published
- 2023
- Full Text
- View/download PDF
10. Pronostic à un mois des patients de plus de 75 ans fragiles consultant aux urgences
- Author
-
Maarek, L., primary, Javaud, N., additional, Maarek, Laura, additional, Maillet, Florent, additional, Turki, Aicha, additional, altar, Adrien, additional, Haguenauer, Didier, additional, Bardis, Alexandre, additional, Simon, Agathe-Raynaud, additional, Achamlal, Jallal, additional, Cailleaux, Pierre-Emmanuel, additional, and Javaud, Nicolas, additional
- Published
- 2020
- Full Text
- View/download PDF
11. [Acquired angioedema due to C1-inhibitor deficiency: CREAK recommendations for diagnosis and treatment]
- Author
-
Gobert, D., Bouillet, L., Armengol, G., Coppo, P., Defendi, F., Du-Thanh, A., Hardy, G., Javaud, N., Jeandel, P.-Y., Launay, D., Panayotopoulos, V., Pelletier, F., Boccon-Gibod, I., Fain, O., Service de médecine interne [CHU Saint-Antoine], CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre de référence des angioedèmes à kinines (CREAK), Université Joseph Fourier - Grenoble 1 (UJF)-CHU Grenoble, Centre Hospitalier Universitaire [Grenoble] (CHU), CHU Rouen, Normandie Université (NU), Service d'hématologie clinique et de thérapie cellulaire [CHU Saint-Antoine], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), CHU Montpellier, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Pathogénèse et contrôle des infections chroniques (PCCI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre Hospitalier Universitaire de Montpellier (CHU Montpellier ), Centre Hospitalier Universitaire de Nice (CHU Nice), Institute for Translational Research in Inflammation - U 1286 (INFINITE (Ex-Liric)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), CHU Lille, Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Gestionnaire, Hal Sorbonne Université, Centre de référence national des angiœdèmes (CREAK), and CHU Grenoble-Université Grenoble Alpes (UGA)
- Subjects
Bradykinine ,[SDV]Life Sciences [q-bio] ,C1-inhibitor ,Comorbidity ,Angiœdème acquis ,Bradykinin ,Chemoprevention ,Diagnosis, Differential ,C1-inhibiteur ,Internal Medicine ,Humans ,Déficit acquis en C1-inhibiteur ,Angioedema ,Diagnostic Techniques and Procedures ,Societies, Medical ,Angiœdème bradykinique ,Acquired C1-inhibitor deficiency ,Angioedemas, Hereditary ,Middle Aged ,Reference Standards ,Hematologic Diseases ,[SDV] Life Sciences [q-bio] ,Tranexamic Acid ,France ,Rituximab ,Bradykininin angioedema - Abstract
Acquired angioedema with C1-inhibitor deficiency is a rare and peculiar entity belonging to the spectrum of bradykinin angioedemas. It usually occurs in subjects over 60 years old, and is mostly associated with a B-cell lymphoid hemopathy or a monoclonal gammopathy.The diagnosis relies on at least one angioedema episode, lasting more than 24 h, and on the decrease of functional C1-inhibitor. Low C1q is observed in 90% of patients, and an anti C1-inhibitor antibody is found in 50% of patients.The treatment of severe attacks relies on icatibant or C1-inhibitor perfusions. Long term prophylaxis in patients with frequent attacks requires treatment of the associated hemopathy if so. In case of idiopathic angioedema, tranexamic acid and danazol may be used, provided that there is-no thrombophilia; as well as rituximab as second-line treatment. Inhibitors of kallikrein still need to be evaluated in this therapeutic indication., Les angiœdèmes par déficit acquis en C1-inhibiteur représentent une entité rare au sein des angiœdèmes bradykiniques. Ils diffèrent des formes héréditaires essentiellement par le terrain, car ils surviennent chez des sujets âgés de 60 ans en moyenne, et sont, le plus souvent, associés à une hémopathie lymphoïde B de bas grade ou à une gammapathie monoclonale.Leur diagnostic repose sur la survenue d'au moins un épisode d'angiœdème durant plus de 24 heures et sur la diminution de C1-inhibiteur fonctionnel. Une baisse du C1q est présente dans 90 % des cas et un anticorps anti C1-inhibiteur chez 50 % des patients.Le traitement des crises sévères repose sur l'icatibant ou l'administration de C1-inhibiteur. Le traitement préventif, indiqué en cas de crises fréquentes, nécessite le traitement de l'hémopathie identifiée. En l'absence de pathologie associée, l'acide tranexamique ou le danazol sont des options à envisager en l'absence de facteur de risque de thrombose, et le rituximab peut être proposé en cas d'échec. La place des inhibiteurs de la kallicréine sera à définir dans cette indication.
- Published
- 2020
- Full Text
- View/download PDF
12. Association Between Pulmonary Embolism and COVID-19 in Emergency Department Patients Undergoing Computed Tomography Pulmonary Angiogram: The PEPCOV International Retrospective Study
- Author
-
Freund Y, Drogrey M, Miro O, Marra A, Feral-Pierssens A, Penaloza A, Hernandez B, Beaune S, Gorlicki J, Ayar P, Truchot J, Pena B, Aguirre A, Femy F, Javaud N, Chauvin A, Chouihed T, Montassier E, Claret P, Occelli C, Roussel M, Brigant F, Ellouze S, Le Borgne P, Laribi S, Simon T, Lucidarme O, Cachanado M, Bloom B, and IMPROVING EMERGENCY CARE FHU
- Abstract
Background There have been reports of procoagulant activity in patients with COVID-19. Whether there is an association between pulmonary embolism (PE) and COVID-19 in the emergency department (ED) is unknown. The aim of this study was to assess whether COVID-19 is associated with PE in ED patients who underwent a computed tomographic pulmonary angiogram (CTPA). Methods A retrospective study in 26 EDs from six countries. ED patients in whom a CTPA was performed for suspected PE during a 2-month period covering the pandemic peak. The primary endpoint was the occurrence of a PE on CTPA. COVID-19 was diagnosed in the ED either on CT or reverse transcriptase-polymerase chain reaction. A multivariable binary logistic regression was built to adjust with other variables known to be associated with PE. A sensitivity analysis was performed in patients included during the pandemic period. Results A total of 3,358 patients were included, of whom 105 were excluded because COVID-19 status was unknown, leaving 3,253 for analysis. Among them, 974 (30%) were diagnosed with COVID-19. Mean (+/- SD) age was 61 (+/- 19) years and 52% were women. A PE was diagnosed on CTPA in 500 patients (15%). The risk of PE was similar between COVID-19 patients and others (15% in both groups). In the multivariable binary logistic regression model, COVID-19 was not associated with higher risk of PE (adjusted odds ratio = 0.98, 95% confidence interval = 0.76 to 1.26). There was no association when limited to patients in the pandemic period. Conclusion In ED patients who underwent CTPA for suspected PE, COVID-19 was not associated with an increased probability of PE diagnosis. These results were also valid when limited to the pandemic period. However, these results may not apply to patients with suspected COVID-19 in general.
- Published
- 2020
13. Efficacité du rituximab dans les angiœdèmes par déficit acquis en C1 inhibiteur : 55 observations
- Author
-
Kalmi, G., primary, Delphine, G., additional, Coppo, P., additional, Defendi, F., additional, Hardy, G., additional, Javaud, N., additional, Mekinian, A., additional, Virginie, P., additional, Boccon-Gibod, I., additional, Bouillet, L., additional, and Fain, O., additional
- Published
- 2019
- Full Text
- View/download PDF
14. Angioedema associated with thrombolysis for ischemic stroke: analysis of a case‐control study
- Author
-
Vigneron, C., primary, Lécluse, A., additional, Ronzière, T., additional, Bouillet, L., additional, Boccon‐Gibod, I., additional, Gayet, S., additional, Doche, E., additional, Smadja, D., additional, Di Legge, S., additional, Dumont, F., additional, Gaudron, M., additional, Ion, I., additional, Marcel, S., additional, Sévin, M., additional, Vlaicu, M. B., additional, Launay, D., additional, Arnaud, I., additional, Girard‐Madoux, P., additional, Héroum, C., additional, Lefèvre, S., additional, Marc, G., additional, Obadia, M., additional, Sablot, D., additional, Sibon, I., additional, Suissa, L., additional, Gobert, D., additional, Detante, O., additional, Alamowitch, S., additional, Fain, O., additional, and Javaud, N., additional
- Published
- 2019
- Full Text
- View/download PDF
15. Awareness is still warranted for ARB s
- Author
-
Javaud, N., primary and Fain, O., additional
- Published
- 2018
- Full Text
- View/download PDF
16. Facteurs associés aux rechutes parmi les patients traités pour urticaire aiguë
- Author
-
Maillet, F., primary, Wolff, D., additional, Soria, A., additional, Adnet, F., additional, Panayotopoulos, V., additional, Gobert, D., additional, Lapostolle, F., additional, Reuter, P.G., additional, Ghazali, A., additional, Caux, F., additional, Fain, O., additional, and Javaud, N., additional
- Published
- 2018
- Full Text
- View/download PDF
17. Angiœdèmes bradykiniques après thrombolyse pour accident vasculaire cérébral : 43 observations
- Author
-
Vigneron, C., primary, Javaud, N., additional, Ronzière, T., additional, Lecluse, A., additional, Gayet, S., additional, Smadja, D., additional, Dumont, F., additional, Gobert, D., additional, Mekinian, A., additional, Bouillet, L., additional, Alamowitch, S., additional, and Fain, O., additional
- Published
- 2018
- Full Text
- View/download PDF
18. Angiœdème bradykinique secondaire aux inhibiteurs de l’enzyme de conversion : instaurer le traitement en préhospitalier
- Author
-
Javaud, N., Fain, O., Bernot, B., Adnet, F., and Lapostolle, F.
- Published
- 2011
- Full Text
- View/download PDF
19. Awareness is still warranted for ARBs.
- Author
-
Javaud, N. and Fain, O.
- Subjects
- *
AWARENESS , *ANGIONEUROTIC edema , *ACE inhibitors , *LONGITUDINAL method , *ACQUISITION of data , *ANGIOTENSIN receptors - Abstract
Click here to view the Original article by Dr. Rasmussen et al. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
20. Diagnostic of Electrocardiogram Abnormalities by Residents
- Author
-
Akodad, H., primary, Javaud, N., additional, Petrovic, T., additional, Reuter, P., additional, Orer, P., additional, Adnet, F., additional, and Lapostolle, F., additional
- Published
- 2014
- Full Text
- View/download PDF
21. Angiœdèmes bradykiniques : facteurs associés à une hospitalisation en réanimation
- Author
-
Javaud, N., primary, Gontier, F., additional, Floccard, B., additional, Boccon-Gibod, I., additional, Amarger, S., additional, Martin, L., additional, Boumediene, A., additional, Coppere, B., additional, Ollivier, Y., additional, Bouillet, L., additional, Adnet, F., additional, and Fain, O., additional
- Published
- 2013
- Full Text
- View/download PDF
22. Sévérité des angiœdèmes bradykiniques médicamenteux : étude comparative avec les formes héréditaires
- Author
-
Javaud, N., primary, Charpentier, S., additional, Lapostolle, F., additional, Lekouara, D., additional, Boubaya, M., additional, Lenoir, G., additional, Mekinian, A., additional, Adnet, F., additional, and Fain, O., additional
- Published
- 2012
- Full Text
- View/download PDF
23. Les angiœdèmes bradykiniques aux urgences
- Author
-
Javaud, N., primary, Karami, A., additional, Stirnemann, J., additional, Chassaignon, C., additional, Branellec, A., additional, Pilot, F., additional, Adnet, F., additional, and Fain, O., additional
- Published
- 2011
- Full Text
- View/download PDF
24. Vascularites cérébrales tuberculeuses : 10 observations
- Author
-
Da Silva Certal, R., primary, Javaud, N., additional, Stirnemann, J., additional, Fantin, B., additional, Bouchaud, O., additional, Chamouard, J.-M., additional, Carpentier, A., additional, Dhôte, R., additional, and Fain, O., additional
- Published
- 2009
- Full Text
- View/download PDF
25. Prise en charge aux urgences des hémorragies digestives hautes extériorisées : l’utilisation d’érythromycine IV permet d’éviter la pose d’une sonde gastrique ; étude multicentrique randomisée
- Author
-
Debuc, E., primary, Vicaut, E., additional, Sahraoui, K., additional, Adnet, F., additional, Bobbia, X., additional, Javaud, N., additional, Ray, P., additional, and Pateron, D., additional
- Published
- 2009
- Full Text
- View/download PDF
26. Décision de réanimer en cas d'état de mort apparente: effet du médecin
- Author
-
Picard, N., primary, Boursier, F., additional, Youssef, M., additional, Javaud, N., additional, Cerceau, J., additional, Guillerm Arri, A., additional, Chalumeau, D., additional, and Sebbah, J.-L., additional
- Published
- 2007
- Full Text
- View/download PDF
27. Réalité de la médicalisation pré-hospitalière
- Author
-
Picard, N., primary, Boursier, F., additional, Javaud, N., additional, Birlouez, C., additional, Nekhili, N., additional, Paule, T., additional, Thevenin, D., additional, and Sebbah, J.-L., additional
- Published
- 2007
- Full Text
- View/download PDF
28. Fièvre chez la femme enceinte
- Author
-
Javaud, N., primary and Stirnemann, J., additional
- Published
- 2007
- Full Text
- View/download PDF
29. Bradykinin-mediated angioedema: factors prompting ED visits.
- Author
-
Javaud N, Karami A, Stirnemann J, Pilot F, Branellec A, Boubaya M, Chassaignon C, Adnet F, and Fain O
- Abstract
OBJECTIVE: Bradykinin-mediated angioedema (AE) is characterized by periodic subcutaneous or submucosal swelling, with the absence of urticaria and itching. It affects the face and extremities. Attacks of abdominal pain and obstruction of the upper airways are the hallmarks of disease severity. The aim of this study was to determine the factors prompting patients to turn up at the hospital emergency department (ED) in the event of an attack. METHODS: This was a retrospective review of attacks experienced by all patients with bradykinin-mediated AE (hereditary, acquired, or drug-induced) who visited our ED between January 2002 and March 2011. Characteristics of attacks prompting ED visits and attacks when patients stayed at home were compared using logistic regression with generalized estimating equations to take into account the correlation between multiple attacks from the same patient. RESULTS: A total of 55 patients were included, of whom 39 had hereditary AE; 13, drug-induced AE; and 3, acquired C1 inhibitor deficiency. The median follow-up was 32 months (interquartile range, 10-99 months). The attack was severe in 324 (58%) of 559 cases. Thirty-two patients (58%) visited the ED for a total of 75 attacks. First attack and laryngeal edema were significantly associated with more frequent ED visits (odds ratio, 5.28 [95% confidence interval, 2.42-11.5] and 4.83 [1.54-15.5], respectively]. C1 inhibitor concentrate and icatibant treatment was significantly more often administered in the ED than at home (odds ratio, 4.9 [2.43-9.88] and 8.25 [2.4-28.3], respectively). CONCLUSIONS: First attack of bradykinin AE and swelling of the larynx were significantly associated with visits to the ED. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
30. Renal granulomatoses: a retrospective study of 40 cases and review of the literature.
- Author
-
Javaud N, Belenfant X, Stirnemann J, Laederich J, Ziol M, Callard P, Ronco P, Rondeau E, Fain O, Javaud, Nicolas, Belenfant, Xavier, Stirnemann, Jérôme, Laederich, Joëlle, Ziol, Marianne, Callard, Patrice, Ronco, Pierre, Rondeau, Eric, and Fain, Olivier
- Published
- 2007
- Full Text
- View/download PDF
31. Temporal Trends in the Use of Computed Tomographic Pulmonary Angiography for Suspected Pulmonary Embolism in the Emergency Department : A Retrospective Analysis.
- Author
-
Roussel M, Bloom B, Taalba M, Choquet C, Douillet D, Fémy F, Marouk A, Gorlicki J, Gerlier C, Macrez R, Arnaud E, Bompard R, Montassier E, Hugli O, Czopik C, Eyer X, Benhamed A, Peyrony O, Chouihed T, Penaloza A, Marra A, Laribi S, Reuter PG, Behringer W, Douplat M, Guenezan J, Javaud N, Lucidarme O, Cachanado M, Aparicio-Monforte A, and Freund Y
- Subjects
- Humans, Female, Middle Aged, Male, Retrospective Studies, Emergency Service, Hospital, Angiography, Tomography, X-Ray Computed, Pulmonary Embolism diagnostic imaging
- Abstract
Background: Recently, validated clinical decision rules have been developed that avoid unnecessary use of computed tomographic pulmonary angiography (CTPA) in patients with suspected pulmonary embolism (PE) in the emergency department (ED)., Objective: To measure any resulting change in CTPA use for suspected PE., Design: Retrospective analysis., Setting: 26 European EDs in 6 countries., Patients: Patients with CTPA performed for suspected PE in the ED during the first 7 days of each odd month between January 2015 and December 2019., Measurements: The primary end points were the CTPAs done for suspected PE in the ED and the number of PEs diagnosed in the ED each year adjusted to an annual census of 100 000 ED visits. Temporal trends were estimated using generalized linear mixed regression models., Results: 8970 CTPAs were included (median age, 63 years; 56% female). Statistically significant temporal trends for more frequent use of CTPA (836 per 100 000 ED visits in 2015 vs. 1112 in 2019; P < 0.001), more diagnosed PEs (138 per 100 000 in 2015 vs. 164 in 2019; P = 0.028), a higher proportion of low-risk PEs (annual percent change [APC], 13.8% [95% CI, 2.6% to 30.1%]) with more ambulatory management (APC, 19.3% [CI, 4.1% to 45.1%]), and a lower proportion of intensive care unit admissions (APC, -8.9% [CI, -17.1% to -0.3%]) were observed., Limitation: Data were limited to 7 days every 2 months., Conclusion: Despite the recent validation of clinical decision rules to limit the use of CTPA, an increase in the CTPA rate along with more diagnosed PEs and especially low-risk PEs were instead observed., Primary Funding Source: None specific for this study., Competing Interests: Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M22-3116.
- Published
- 2023
- Full Text
- View/download PDF
32. Hereditary angioedema: is there a better future for treatment?
- Author
-
Javaud N and Gobert D
- Subjects
- Humans, Complement C1 Inhibitor Protein therapeutic use, Angioedemas, Hereditary diagnosis, Angioedemas, Hereditary drug therapy
- Abstract
Competing Interests: DG declares consultancies, speakers' fees, and travel or accommodation payments by Takeda, Biocryst, Pharming, Kalvista, and CSL Behring. NJ declares no competing interests.
- Published
- 2023
- Full Text
- View/download PDF
33. The Response of Emergency Departments (EDs) to the COVID-19 Pandemic: The Experience of 5 EDs in a Paris-Based Academic Hospital Trust.
- Author
-
Ghazali DA, Choquet C, Bouzid D, Peyrony O, Fontaine JP, Sonja C, Javaud N, Plaisance P, Revue E, Chauvin A, and Casalino E
- Subjects
- Humans, Pandemics, Paris epidemiology, Trust, Emergency Service, Hospital, Hospitals, COVID-19 epidemiology
- Abstract
The coronavirus disease-2019 (COVID-19) pandemic has imposed unforeseen and unprecedented constraints on emergency departments (EDs). In this study, we detail the organizational and managerial tools recently implemented among 5 academic EDs in a French region particularly affected by COVID-19 and analyze how EDs responded to the COVID-19-related disease burden during different phases of the epidemic. Initially, they focused on the early detection of suspected cases by identifying 3 predominant COVID-19 syndromes. During this diagnostic process, patients were placed in respiratory isolation (facial mask before triage) and droplet isolation (ED rooms). A 3-level strategy for triage, clinical pathways in the EDs, and the organization of hospital spaces was based on the real-time polymerase chain reaction (RT-PCR) COVID-19 positivity rate, with ED strategies adapted to the exigencies of each level. This crisis demonstrated hospitals' adaptability and capacity to mobilize in the face of new risks, with hospitals and EDs coordinating their management to reallocate resources, optimize interoperability, and rethink patient pathways. This report on their processes may assist hospitals and EDs in areas currently spared by the new variants., Competing Interests: The authors declare no conflicts of interest., (Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
34. Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments : A Retrospective Cohort Study.
- Author
-
Bouzid D, Visseaux B, Kassasseya C, Daoud A, Fémy F, Hermand C, Truchot J, Beaune S, Javaud N, Peyrony O, Chauvin A, Vaittinada Ayar P, Bourg A, Riou B, Marot S, Bloom B, Cachanado M, Simon T, and Freund Y
- Subjects
- Adult, Emergency Service, Hospital, Female, Humans, Male, Middle Aged, Paris epidemiology, Retrospective Studies, COVID-19, SARS-CoV-2 genetics
- Abstract
Background: At the end of 2021, the B.1.1.529 SARS-CoV-2 variant (Omicron) wave superseded the B.1.617.2 variant (Delta) wave., Objective: To compare baseline characteristics and in-hospital outcomes of patients with SARS-CoV-2 infection with the Delta variant versus the Omicron variant in the emergency department (ED)., Design: Retrospective chart reviews., Setting: 13 adult EDs in academic hospitals in the Paris area from 29 November 2021 to 10 January 2022., Patients: Patients with a positive reverse transcriptase polymerase chain reaction (RT-PCR) test result for SARS-CoV-2 and variant identification., Measurements: Main outcome measures were baseline clinical and biological characteristics at ED presentation, intensive care unit (ICU) admission, mechanical ventilation, and in-hospital mortality., Results: A total of 3728 patients had a positive RT-PCR test result for SARS-CoV-2 during the study period; 1716 patients who had a variant determination (818 Delta and 898 Omicron) were included. Median age was 58 years, and 49% were women. Patients infected with the Omicron variant were younger (54 vs. 62 years; difference, 8.0 years [95% CI, 4.6 to 11.4 years]), had a lower rate of obesity (8.0% vs. 12.5%; difference, 4.5 percentage points [CI, 1.5 to 7.5 percentage points]), were more vaccinated (65% vs. 39% for 1 dose and 22% vs. 11% for 3 doses), had a lower rate of dyspnea (26% vs. 50%; difference, 23.6 percentage points [CI, 19.0 to 28.2 percentage points]), and had a higher rate of discharge home from the ED (59% vs. 37%; difference, 21.9 percentage points [-26.5 to -17.1 percentage points]). Compared with Delta, Omicron infection was independently associated with a lower risk for ICU admission (adjusted difference, 11.4 percentage points [CI, 8.4 to 14.4 percentage points]), mechanical ventilation (adjusted difference, 3.6 percentage points [CI, 1.7 to 5.6 percentage points]), and in-hospital mortality (adjusted difference, 4.2 percentage points [CI, 2.0 to 6.5 percentage points])., Limitation: Patients with COVID-19 illness and no SARS-CoV-2 variant determination in the ED were excluded., Conclusion: Compared with the Delta variant, infection with the Omicron variant in patients in the ED had different clinical and biological patterns and was associated with better in-hospital outcomes, including higher survival., Primary Funding Source: None.
- Published
- 2022
- Full Text
- View/download PDF
35. A national population-based study of patients, bystanders and contextual factors associated with resuscitation in witnessed cardiac arrest: insight from the french RéAC registry.
- Author
-
Reuter PG, Baert V, Colineaux H, Escutnaire J, Javaud N, Delpierre C, Adnet F, Loeb T, Charpentier S, Lapostolle F, Hubert H, and Lamy S
- Subjects
- Adolescent, Humans, Logistic Models, Registries, Social Deprivation, Cardiopulmonary Resuscitation, Emergency Medical Services, Out-of-Hospital Cardiac Arrest epidemiology, Out-of-Hospital Cardiac Arrest therapy
- Abstract
Background: In out-of-hospital cardiac arrest (OHCA), bystander initiated cardiopulmonary resuscitation (CPR) increases the chance of return of spontaneous circulation and survival with a favourable neurological status. Socioeconomic disparities have been highlighted in OHCA field. In areas with the lowest average socioeconomic status, OHCA incidence increased, and bystander CPR decreased. Evaluations were performed on restricted geographical area, and European evaluation is lacking. We aimed to analyse, at a national level, the impact of area-level social deprivation on the initiation of CPR in case of a witnessed OHCA., Methods: We included all witnessed OHCA cases with age over 18 years from July 2011 to July 2018 form the OHCA French national registry. We excluded OHCA occurred in front of rescue teams or in nursing home, and patients with incomplete address or partial geocoding. We collected data from context, bystander and patient. The area-level social deprivation was estimated by the French version of the European Deprivation Index (in quintile) associated with the place where OHCA occurred. We assessed the associations between Utstein variables and social deprivation level using a mixed-effect logit model with bystander-initiated CPR., Results: We included 23,979 witnessed OHCA of which 12,299 (51%) had a bystander-initiated CPR. More than one third of the OHCA (8,326 (35%)) occurred in an area from the highest quintile of social deprivation. The higher the area-level deprivation, the less the proportion of bystander-initiated CPR (56% in Quintile 1 versus 48% in Quintile 5). The In the multivariable analysis, bystander less often began CPR in areas with the highest deprivation level, compared to those with the lowest deprivation level (OR=0.69, IC95%: 0.63-0.75)., Conclusions: The level of social deprivation of the area where OHCA occurred was associated with bystander-initiated CPR. It decreased in the more deprived areas although these areas also concentrate more younger patients., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
36. Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial.
- Author
-
Roy PM, Penaloza A, Hugli O, Klok FA, Arnoux A, Elias A, Couturaud F, Joly LM, Lopez R, Faber LM, Daoud-Elias M, Planquette B, Bokobza J, Viglino D, Schmidt J, Juchet H, Mahe I, Mulder F, Bartiaux M, Cren R, Moumneh T, Quere I, Falvo N, Montaclair K, Douillet D, Steinier C, Hendriks SV, Benhamou Y, Szwebel TA, Pernod G, Dublanchet N, Lapebie FX, Javaud N, Ghuysen A, Sebbane M, Chatellier G, Meyer G, Jimenez D, Huisman MV, and Sanchez O
- Subjects
- Acute Disease, Humans, Patient Discharge, Prognosis, Risk Assessment, Severity of Illness Index, Pulmonary Embolism drug therapy
- Abstract
Aims: The aim of this study is to compare the Hestia rule vs. the simplified Pulmonary Embolism Severity Index (sPESI) for triaging patients with acute pulmonary embolism (PE) for home treatment., Methods and Results: Normotensive patients with PE of 26 hospitals from France, Belgium, the Netherlands, and Switzerland were randomized to either triaging with Hestia or sPESI. They were designated for home treatment if the triaging tool was negative and if the physician-in-charge, taking into account the patient's opinion, did not consider that hospitalization was required. The main outcomes were the 30-day composite of recurrent venous thrombo-embolism, major bleeding or all-cause death (non-inferiority analysis with 2.5% absolute risk difference as margin), and the rate of patients discharged home within 24 h after randomization (NCT02811237). From January 2017 through July 2019, 1975 patients were included. In the per-protocol population, the primary outcome occurred in 3.82% (34/891) in the Hestia arm and 3.57% (32/896) in the sPESI arm (P = 0.004 for non-inferiority). In the intention-to-treat population, 38.4% of the Hestia patients (378/984) were treated at home vs. 36.6% (361/986) of the sPESI patients (P = 0.41 for superiority), with a 30-day composite outcome rate of 1.33% (5/375) and 1.11% (4/359), respectively. No recurrent or fatal PE occurred in either home treatment arm., Conclusions: For triaging PE patients, the strategy based on the Hestia rule and the strategy based on sPESI had similar safety and effectiveness. With either tool complemented by the overruling of the physician-in-charge, more than a third of patients were treated at home with a low incidence of complications., (© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.)
- Published
- 2021
- Full Text
- View/download PDF
37. Efficacy of emergency medical center use of a protocol during telephone calls to give medical advice related to fever or gastroenteritis: a cluster randomized controlled trial.
- Author
-
Reuter PG, Durand-Zaleski I, Ducros O, Grignon O, Megy-Michoux I, Sourbes A, Desmettre T, Javaud N, Lapostolle F, Vicaut E, and Adnet F
- Subjects
- Clinical Protocols, Humans, Telephone, Emergency Service, Hospital, Fever therapy, Gastroenteritis therapy
- Abstract
Objectives: To determine the efficacy of emergency medical center physicians' use of a protocol to guide their management of telephone consultations for fever and gastroenteritis., Material and Methods: Cluster randomized controlled trial. Participating centers were randomized to use the telephone protocol or provide usual telephone assistance. Six emergency centers in France included calls from patients needing advice on fever or gastroenteritis. Centers assigned to the protocol followed specific guidelines on managing the call and giving advice on treatment. Primary endpoints were the number of in-person visits and hospital admissions required within 15 days of the call. Secondary endpoints were patient satisfaction and costs., Results: A total of 2498 calls were included. Use of the assigned protocol while attending 1234 calls was associated with a relative risk for hospitalization or an unscheduled in-person visit for care of 0.70 (95% CI, 0.58-0.85) versus usual practice. Ambulance use, admission to an intensive care unit, mortality, morbidity, and symptom improvement did not differ significantly between centers using the protocol and those following usual practice. Ninety percent of the patients were satisfied. The cost of care was €91 in centers applying the protocol and €150 in the other centers (P .01)., Conclusion: Use of the protocol was associated with fewer unscheduled in-person visits for care and fewer hospital admissions. The protocol is safe and less costly than the centers' usual approaches to giving telephone advice.
- Published
- 2021
38. How Can a Deep Learning Algorithm Improve Fracture Detection on X-rays in the Emergency Room?
- Author
-
Reichert G, Bellamine A, Fontaine M, Naipeanu B, Altar A, Mejean E, Javaud N, and Siauve N
- Abstract
The growing need for emergency imaging has greatly increased the number of conventional X-rays, particularly for traumatic injury. Deep learning (DL) algorithms could improve fracture screening by radiologists and emergency room (ER) physicians. We used an algorithm developed for the detection of appendicular skeleton fractures and evaluated its performance for detecting traumatic fractures on conventional X-rays in the ER, without the need for training on local data. This algorithm was tested on all patients ( N = 125) consulting at the Louis Mourier ER in May 2019 for limb trauma. Patients were selected by two emergency physicians from the clinical database used in the ER. Their X-rays were exported and analyzed by a radiologist. The prediction made by the algorithm and the annotation made by the radiologist were compared. For the 125 patients included, 25 patients with a fracture were identified by the clinicians, 24 of whom were identified by the algorithm (sensitivity of 96%). The algorithm incorrectly predicted a fracture in 14 of the 100 patients without fractures (specificity of 86%). The negative predictive value was 98.85%. This study shows that DL algorithms are potentially valuable diagnostic tools for detecting fractures in the ER and could be used in the training of junior radiologists.
- Published
- 2021
- Full Text
- View/download PDF
39. Reducing pain by using venous blood gas instead of arterial blood gas (VEINART): a multicentre randomised controlled trial.
- Author
-
Chauvin A, Javaud N, Ghazali A, Curac S, Altar A, Ali T, Beguin N, Bellier J, Coupier A, Delsarte L, Dreyfuss D, Kheirbek N, Oudar C, Stordeur Y, Weiss M, Gaudry S, Lambert J, and Roux D
- Subjects
- Adult, Aged, Aged, 80 and over, Arteries, Emergency Service, Hospital, Female, France, Humans, Male, Middle Aged, Pain Measurement, Prospective Studies, Veins, Blood Gas Analysis methods, Pain Management methods
- Abstract
Introduction: Venous sampling for blood gas analysis has been suggested as an alternative to arterial sampling in order to reduce pain. The main objective was to compare pain induced by venous and arterial sampling and to assess whether the type of sampling would affect clinical management or not., Methods: We performed an open-label randomised multicentre prospective study in four French EDs during a 4-week period. Non-hypoxaemic adults, whose medical management required blood gas analysis, were randomly allocated using a computer-generated randomisation list stratified by centres with an allocation ratio of 1:1 using random blocks to one of the two arms: venous or arterial sampling. The primary outcome was the maximal pain during sampling, using the visual analogue scale. Secondary outcomes pertained to ease of sampling as rated by the nurse drawing the blood, and physician satisfaction regarding usefulness of biochemical data., Results: 113 patients were included: 55 in the arterial and 58 in the venous sampling group. The mean maximal pain was 40.5 mm±24.9 mm and 22.6 mm±20.2 mm in the arterial group and the venous group, respectively, accounting for a mean difference of 17.9 mm (95% CI 9.6 to 26.3) (p<0.0001). Ease of blood sampling was greater in the venous group as compared with the arterial group (p=0.02). The usefulness of the results, evaluated by the prescriber, did not significantly differ (p=0.25)., Conclusions: Venous blood gas is less painful for patients than ABG in non-hypoxaemic patients. Venous blood gas should replace ABG in this setting., Trial Registration Number: NCT03784664., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2020
- Full Text
- View/download PDF
40. Prognosis of non-severely comorbid elderly patients admitted to emergency departments: A prospective study.
- Author
-
Maarek L, Maillet F, Turki A, Altar A, Hamdi H, Berroukeche M, Haguenauer D, Chemouny M, Cailleaux PE, and Javaud N
- Subjects
- Aged, Aged, 80 and over, Comorbidity trends, Emergency Service, Hospital organization & administration, Emergency Service, Hospital statistics & numerical data, Female, Hospitalization statistics & numerical data, Humans, Male, Paris, Prospective Studies, Prognosis
- Abstract
Competing Interests: Declaration of Competing Interest None.
- Published
- 2020
- Full Text
- View/download PDF
41. Professional practice assessment for minor head injury management in emergency department and clinical impact of a simulation-based training: Interventional study (before/after).
- Author
-
Vandingenen P, Chauvin A, Javaud N, and Ghazali DA
- Subjects
- Guideline Adherence, Humans, Reproducibility of Results, Tomography, X-Ray Computed, Craniocerebral Trauma diagnosis, Craniocerebral Trauma therapy, Emergency Service, Hospital standards, Professional Practice standards, Simulation Training
- Abstract
Background: Minor head injury is a frequent reason for consultation in the emergency department. The use of computed tomography (CT) has increased dramatically in patients' care. Good time management implementation and interpretation are required. To study the level of agreement with recommendations for a minor head injury in emergency department management and the impacts of simulation-based training (SBT) on professional practice changes., Methods: Evaluation of professional practice for patient care in an emergency department according to the recommendations of the French Emergency Medicine Society (SFMU) established in 2012 before and after an SBT, including theoretical and simulation courses. It was based on the analysis of time to carry out a CT scan. It was also based on analysis of adherence to brain and spine scan indications and to hospitalization criteria., Results: The SBT carried out in the evaluation of the professional practices makes it possible to acquire the notion of urgency to obtain the CT Scan within one hour when the criteria are met (p=0.007). Rater reliability for agreement with the hospitalization recommendations was better after SBT (p=0.03, increased Kappa from 0.73 to 0.93). On the other hand, there appeared to be a lack of essential information in the medical file, such as time of onset of head trauma., Conclusion: Management of this type of patient appeared to be satisfactory. It can be improved by SBT on the basis of the SFMU 2012 consensus conference. There is a need to improve the software used by the emergency departments, which should include the time of trauma and recommendations. The association of the clinic and the biomarkers could help to limit the indications of the CT scan, and thus to have it organized more rapidly.
- Published
- 2020
- Full Text
- View/download PDF
42. Interventional studies performed in emergency medical communication centres: systematic review.
- Author
-
Reuter PG, Chauvin A, Javaud N, Adnet F, Lapostolle F, and Yordanov Y
- Subjects
- Biomedical Research methods, Clinical Trials as Topic methods, Emergency Medical Service Communication Systems, Humans, Call Centers methods, Call Centers organization & administration, Health Services Research methods
- Abstract
We aimed to both quantitatively and qualitatively describe interventional research performed in emergency medical communication centres. We conducted a systematic review of articles published in MEDLINE, Cochrane Central Register of Controlled Trials and Web of Science. Studies evaluating therapeutic or organizational interventions directed by call centres in the context of emergencies were included. Studies of call centre management for general practice or nonhealthcare agencies were excluded. We assessed general characteristics and methodological information for each study. Quality was evaluated by the Cochrane Risk of Bias tool or the Newcastle-Ottawa Scale. Among 3896 articles screened, we retained 59; 41 studies were randomized controlled trials (69%) and 18 (31%) were before-after studies; 41 (69%) took place in a single centre. For 33 (56%), 22 (37%) and 4 (7%) studies, the models used were simulation training, patient-based or experimental, respectively. The main topic was cardiac arrests (n = 45, 76%), with outcome measures of cardiopulmonary resuscitation quality and dispatch assistance. Among randomized controlled trials, risk of bias was unclear or high for selective reporting for 37 (90%) studies, low for blinding of outcomes for 34 (83%) and low for incomplete outcomes for 31 (76%). Regarding before-after studies, quality was high in 9 (50%) studies. Few interventional studies have been performed in call centres. Studies mainly involved simulation and focussed on cardiac arrest. The quality of studies needs improvement to allow for a better recognition and understanding of emergency medical call control.
- Published
- 2020
- Full Text
- View/download PDF
43. Hereditary angioedema, emergency management of attacks by a call center.
- Author
-
Javaud N, Altar A, Fain O, Reuter PG, Desmaizieres M, Petrovic T, Ghazali A, Durand-Zaleski I, Bouillet L, Vicaut E, Launay D, Martin L, Floccard B, Gompel A, Sobel A, Boccon-Gibod I, Kanny G, Lapostolle F, and Adnet F
- Subjects
- Acute Disease, Adult, Female, Humans, Male, Middle Aged, Prospective Studies, Angioedemas, Hereditary therapy, Call Centers statistics & numerical data, Emergency Treatment
- Abstract
Objective: Hereditary angiœdema (HAE) is a rare autosomal dominant disease characterized by recurrent, unpredictable, potentially life-threatening swelling. Objective is to assess the management of the acute HAE attacks in the real life setting through a call center in France., Methods: A pre-specified ancillary study of SOS-HAE, a cluster-randomized prospective multicenter trial, was conducted. HAE patients were recruited from 8 participating reference centers. The outcome of interest was the rate of hospitalization., Results: onerhundred patients were included. The median (quartile) age was 38 (29-53) years, and 66 (66%) were female. Eighty (80%) patients had HAE type I, 8 (8%) had HAE type II and 12 (12%) patients had FXII-HAE. Fifty-one (51%) patients had experienced at least one time the call center during the follow-up. Nine over 166 (5%) attacks for 9 different patients resulted in hospital admission to the hospital (in the short-stay unit, ie, <24 h) during the follow-up period. During 2 years, there were 166 calls to call center for 166 attacks. All attacks were treated at home after call center contact., Conclusions: Use of emergency departments and hospitalizations are reduced by the use of a coordinated national call center in HAE after therapeutic education program that promoted self-administration of specific treatment and use of call to call center., Trial Registration: clinicalTrials.gov identifier: NCT01679912., (Copyright © 2019 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
44. Glucocorticoids for acute urticaria: study protocol for a double-blind non-inferiority randomised controlled trial.
- Author
-
Javaud N, Soria A, Maignan M, Martin L, Descamps V, Fain O, Bouillet L, Berard F, Tazarourte K, Roy PM, Fontaine JP, Bagot M, Khellaf M, Goulet H, Lapostolle F, Casalino E, Doutre MS, Gil-Jardine C, Caux F, Chosidow O, Pateron D, Vicaut E, and Adnet F
- Subjects
- Adult, Female, Humans, Male, Middle Aged, Acute Disease, Dose-Response Relationship, Drug, Double-Blind Method, Follow-Up Studies, Glucocorticoids administration & dosage, Histamine H1 Antagonists administration & dosage, Prospective Studies, Quality of Life, Recurrence, Treatment Outcome, Randomized Controlled Trials as Topic, Multicenter Studies as Topic, Cetirizine administration & dosage, Prednisone administration & dosage, Urticaria drug therapy
- Abstract
Introduction: This study protocol describes a trial designed to investigate whether antihistamine alone in patients with acute urticaria does not increase the 7-day Urticaria Activity Score (UAS7) in comparison with an association of antihistamine and glucocorticoids and reduces short-term relapses and chronic-induced urticaria., Methods and Analysis: This is a prospective, double-blind, parallel-group, multicentre non-inferiority randomised controlled trial. Two-hundred and forty patients with acute urticaria admitted to emergency department will be randomised in a 1:1 ratio to receive levocetirizine or an association of levocetirizine and prednisone. Randomisation will be stratified by centre. The primary outcome will be the UAS7 at day 7. The secondary outcomes will encompass recurrence of hives and/or itch at day 7; occurrence of spontaneous hives or itch for >6 weeks; patients with angioedema at day 7, and 2, 6, 12 and 24 weeks; new emergency visits for acute urticaria recurrences at days 7 and 14, and 3 months; Dermatology Life Quality Index at days 7 and 14, and 3 and 6 months; and Chronic Urticaria Quality of Life Questionnaire at 6 weeks., Ethics and Dissemination: The protocol has been approved by the Comité de Protection des Personnes Sud-Méditerranée II and will be carried out in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. A steering committee will oversee the progress of the study. Findings will be disseminated through national and international scientific conferences and publication in peer-reviewed journals., Trial Registration Number: NCT03545464., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2019
- Full Text
- View/download PDF
45. Longer symptom onset to aspiration time predicts success of needle aspiration in primary spontaneous pneumothorax.
- Author
-
Vuillard C, Dib F, Achamlal J, Gaudry S, Roux D, Chemouny M, Javaud N, Dreyfuss D, Ricard JD, and Messika J
- Subjects
- Adult, Chest Tubes, Female, Humans, Male, Prospective Studies, Retrospective Studies, Time Factors, Treatment Outcome, Pneumothorax surgery, Thoracentesis, Time-to-Treatment
- Abstract
Background: Needle aspiration (NA) is recommended as first-line treatment of primary spontaneous pneumothorax (PSP). We aimed to assess NA success and the effect of a longer symptom onset to NA time., Methods: A discovery phase was retrospectively conducted in the intensive care unit of Louis Mourier Hospital (January 2000 to December 2011) followed by a prospective validation cohort (January 2012 to August 2015). The primary outcome was immediate NA success defined by the absence of need for chest tube insertion within 24 hours of the procedure., Results: In the discovery phase, 130 patients were admitted for PSP and 98 had NA as first-line treatment (75%). The immediate success rate of NA was 34.7% and was higher when it was performed ≥48 hours after symptom onset (57.7% vs 25%; p=0.004). In the prospective cohort, 87 patients were admitted for PSP; 71 (82%) had NA as first-step treatment. The immediate success rate was 40.8%. NA was more successful when it was performed after 48 hours of symptoms' onset (34.5% vs 7.1%; p=0.005). A delay between the first symptom and NA procedure ≥48 hours was associated with a higher success of NA (OR=13.54; 95% CI 1.37 to 133). A smaller pneumothorax estimated by Light's index was associated with NA success (OR=0.95; 95% CI 0.92 to 0.98). To what extent some of these pneumothoraces would have had a spontaneous resolution remains unknown., Conclusion: When managing PSP with NA, a longer symptom onset to NA time was associated with NA success., Trial Registration Number: NCT02528734., Competing Interests: Competing interests: J-DR and JM received reimbursement of congress fees from Fisher & Paykel., (© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2019
- Full Text
- View/download PDF
46. Prognosis of cirrhotic patients admitted to Emergency Departments: A multicenter study.
- Author
-
Javaud N, Bonnin L, Lapostolle F, Boubaya M, Bardis A, Dufau R, Ghazali A, Reuter PG, Pateron D, and Adnet F
- Subjects
- Aged, Female, France epidemiology, Hospital Mortality, Humans, Male, Middle Aged, Prognosis, Retrospective Studies, Emergency Service, Hospital, Liver Cirrhosis mortality
- Abstract
Objectives: Life threatening complications can occur at any stage of cirrhosis progression. There are few studies on the prognosis of cirrhotic patients managed in an Emergency Department (ED) although management of patients will occur in the ED. The objective of our study was to determine the risk factors for mortality in cirrhotic patients who visited to the ED., Methods: All cirrhotic patients attending ED in three different university hospitals of Assistance Publique - Hôpitaux de Paris between January 2014 and June 2015 were identified by a retrospective analysis of digital records and included in the study. The primary end-point was 30-day mortality in all cirrhotic patients who visited the ED., Results: A total of 609 ED visits were analyzed among 224 patients: 115 (51%) presented a cirrhosis of alcoholic origin, 43 (19%) were caused by Hepatitis C, 28 (13%) of mixed origin (viral and alcoholic), 17 (8%) were caused by Hepatitis B and 21 (9%) of other origins. Fifty-five (25%) of these patients died within 30 days of their initial presentation to the ED. In multivariate analysis, the age (Odds Ratio: 1.04 [1.01-1.07]), cirrhosis associated with hepatocellular carcinoma (OR: 3.07 [1.37-6.91]), serum creatinine at admission (OR: 1.01 [1.01-1.02]), serum bilirubin at admission (OR: 1.01 [1.01-1.02]) and health impairment (OR: 2.57 [1.28-5.16]) were associated with mortality., Conclusions: The mortality rate of cirrhotic patients attending an ED was high. The prognosis of cirrhotic patients admitted to the ED depended on the severity of the liver and other organ dysfunction. The presence of a hepatocellular carcinoma on admission was also a risk factor for death., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
47. Factors associated with relapses among patients treated for acute urticaria.
- Author
-
Maillet F, Wolff D, Soria A, Adnet F, Panayotopoulos V, Gobert D, Lapostolle F, Reuter PG, Ghazali A, Caux F, Fain O, and Javaud N
- Subjects
- Acute Disease therapy, Adult, Female, Humans, Male, Middle Aged, Recurrence, Retrospective Studies, Time Factors, Treatment Outcome, Adrenal Cortex Hormones therapeutic use, Urticaria drug therapy
- Abstract
The benefit of corticosteroids in acute urticaria is controversial. Our objective was to determine the factors associated with relapses in patients presenting with acute urticaria. A retrospective observational study, including all patients with acute urticaria who visited the angioedema reference center of Academic Public Hospitals - Saint-Antoine in Paris between January 2015 and June 2017, was conducted. The study inclusion criterion was a diagnosis of acute urticaria in an adult patient. The urticaria was spontaneous or inducible urticaria. The primary outcome was relapse at day 7 and the secondary outcome was relapse at week 6. A total of 184 patients with a first episode of acute urticaria were included. Most of the patients were female (66%) with a mean age of 42 ± 16 years. Corticosteroid administration for treatment of acute urticaria was used in 102 (55%) patients. Overall, 85 (46%) patients had relapses after less than 7 days whereas 168 (91%) patients had relapses after more than 6 weeks. In univariate analysis, the rate of corticosteroid administration was significantly higher in cases of relapse after less than 7 days. No difference in relapse rates after more than 6 weeks appeared. In the multivariate analysis, the independent factor associated with relapses after less than 7 days was the administration of corticosteroids as treatment of acute urticaria (odds ratio, 1.93; 95% confidence interval, 1.06-3.57; P = 0.03). The prevalence of corticosteroid administration for patients with acute urticaria was high. Corticosteroid administration was an independent risk factor associated with relapses after less than 7 days., (© 2019 Japanese Dermatological Association.)
- Published
- 2019
- Full Text
- View/download PDF
48. Hereditary angioedema: Clinical presentation and socioeconomic cost of 200 French patients.
- Author
-
Javaud N, Bouillet L, Rabetrano H, Bitoun A, Launay D, Lapostolle F, Reuter PG, Martin L, Vicaut E, Fain O, Adnet F, and Durand-Zaleski I
- Subjects
- Adult, Angioedemas, Hereditary drug therapy, Angioedemas, Hereditary epidemiology, Female, Follow-Up Studies, France epidemiology, Home Care Services, Humans, Male, Middle Aged, Prospective Studies, Self Care, Angioedemas, Hereditary diagnosis, Complement C1 Inhibitor Protein therapeutic use, Costs and Cost Analysis, Hospitalization statistics & numerical data, Socioeconomic Factors
- Published
- 2019
- Full Text
- View/download PDF
49. Diagnostic biologique des angioedèmes bradykiniques : les recommandations du CREAK.
- Author
-
Bouillet L, Defendi F, Hardy G, Cesbron JY, Boccon-Gibod I, Deroux A, Mansard C, Launay D, Gompel A, Floccard B, Jaussaud R, Beaudouin E, Armengol G, Olliver Y, Gayet S, Du Than A, Sailler L, Guez S, Sarrat A, Sorin L, de Moreuil C, Pelletier F, Javaud N, Marmion N, Fain O, Fauré J, and Dumestre-Pérard C
- Subjects
- Algorithms, Angioedema chemically induced, Angioedema metabolism, Angioedemas, Hereditary classification, Angiotensin-Converting Enzyme Inhibitors adverse effects, Child, Comorbidity, Complement C1 Inhibitor Protein genetics, Early Diagnosis, Factor XII physiology, Female, Fibrinolysin physiology, Hematologic Diseases epidemiology, Hereditary Angioedema Types I and II diagnosis, Hereditary Angioedema Types I and II metabolism, Humans, Kallikreins physiology, Lupus Erythematosus, Systemic epidemiology, Pregnancy, Pregnancy Complications blood, Symptom Assessment, Angioedemas, Hereditary metabolism, Bradykinin metabolism, Complement C1 Inhibitor Protein analysis
- Abstract
Bradykinin mediated angioedema (BK-AE) can be associated either with C1Inhibitor deficiency (hereditary and acquired forms), either with normal C1Inh (hereditary form and drug induced AE as angiotensin converting enzyme inhibitors…). In case of high clinical suspicion of BK-AE, C1Inh exploration must be done at first: C1Inh function and antigenemy as well as C4 concentration. C1Inh deficiency is significant if the tests are below 50 % of the normal values and controlled a second time. In case of C1Inh deficiency, you have to identify hereditary from acquired forms. C1q and anti-C1Inh antibody tests are useful for acquired BK-AE. SERPING1 gene screening must be done if a hereditary angioedema is suspected, even if there is no family context (de novo mutation 15 %). If a hereditary BK-AE with normal C1Inh is suspected, F12 and PLG gene screening is suitable., (Copyright © 2018. Published by Elsevier Masson SAS.)
- Published
- 2019
- Full Text
- View/download PDF
50. Specialist Advice Support for Management of Severe Hereditary Angioedema Attacks: A Multicenter Cluster-Randomized Controlled Trial.
- Author
-
Javaud N, Fain O, Durand-Zaleski I, Launay D, Bouillet L, Gompel A, Sobel A, Woimant M, Rabetrano H, Petrovic T, Lapostolle F, Boccon-Gibod I, Reuter PG, Bertrand P, Mezaour M, Coppere B, Floccard B, Kanny G, Baker E, Martin L, Vicaut E, and Adnet F
- Subjects
- Adult, Androgens therapeutic use, Call Centers, Clinical Competence, Cluster Analysis, Emergency Service, Hospital, Female, Humans, Male, Middle Aged, Progestins therapeutic use, Prospective Studies, Quality-Adjusted Life Years, Tranexamic Acid therapeutic use, Treatment Outcome, Angioedemas, Hereditary drug therapy, Angioedemas, Hereditary epidemiology, Patient Admission statistics & numerical data
- Abstract
Study Objective: Hereditary angioedema is a rare disease associated with unpredictable, recurrent attacks of potentially life-threatening edema. Management of severe attacks is currently suboptimal because emergency medical teams are often unaware of new specific treatments. The objective of this trial is to test whether a dedicated national telephone care-management strategy would reduce resource use during severe hereditary angioedema attacks., Methods: We conducted a cluster-randomized multicenter prospective trial of patients with a documented diagnosis of hereditary angioedema (type I, II or FXII hereditary angioedema). Participants were enrolled between March 2013 and June 2014 at 8 participating reference centers. The randomized units were the reference centers (clusters). Patients in the intervention arm were given a national free telephone number to call in the event of a severe attack. Emergency physicians in the SOS-hereditary angiœdema (SOS-HAE) call center were trained to advise or prescribe specific treatments. The primary outcome was number of admissions for angioedema attacks. Economic evaluation was also performed., Results: We included 100 patients in the SOS-HAE group and 100 in the control group. During the 2 years, there were 2,368 hereditary angioedema attacks among 169 patients (85%). Mean number of hospital admissions per patient in the 2-year period was significantly greater in the usual-practice group (mean 0.16 [range 0 to 2] versus 0.03 [range 0 to 1]); patient risk difference was significant: -0.13 (95% confidence interval -0.22 to -0.04; P=.02). Probabilistic sensitivity graphic analysis indicated a trend toward increased quality-adjusted life-years in the SOS-HAE group., Conclusion: A national dedicated call center for management of severe hereditary angioedema attacks is associated with a decrease in hospital admissions and may be cost-effective if facilities and staff are available to deliver the intervention alongside existing services., (Copyright © 2018 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.